These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24565517)
1. Microvesicle-mediated delivery of transforming growth factor β1 siRNA for the suppression of tumor growth in mice. Zhang Y; Li L; Yu J; Zhu D; Zhang Y; Li X; Gu H; Zhang CY; Zen K Biomaterials; 2014 May; 35(14):4390-400. PubMed ID: 24565517 [TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
3. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD; Isayeva T; Siegal GP; Ponnazhagan S Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771 [TBL] [Abstract][Full Text] [Related]
4. Using adenovirus armed short hairpin RNA targeting transforming growth factor β1 inhibits melanoma growth and metastasis in an ex vivo animal model. Tai KF; Wang CH Ann Plast Surg; 2013 Dec; 71 Suppl 1():S75-81. PubMed ID: 24284745 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma. Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of TGF-β1 and FGF-2 on SDF-1α expression in human periodontal ligament cells derived from deciduous teeth in vitro. Hasegawa T; Chosa N; Asakawa T; Yoshimura Y; Fujihara Y; Kitamura T; Tanaka M; Ishisaki A; Mitome M Int J Mol Med; 2012 Jul; 30(1):35-40. PubMed ID: 22469823 [TBL] [Abstract][Full Text] [Related]
7. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells. Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210 [TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation. Song JJ; Aswad R; Kanaan RA; Rico MC; Owen TA; Barbe MF; Safadi FF; Popoff SN J Cell Physiol; 2007 Feb; 210(2):398-410. PubMed ID: 17111364 [TBL] [Abstract][Full Text] [Related]
9. Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling. Miles FL; Tung NS; Aguiar AA; Kurtoglu S; Sikes RA Prostate; 2012 Sep; 72(12):1339-50. PubMed ID: 22228025 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969 [TBL] [Abstract][Full Text] [Related]
12. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related]
13. The cytotoxic effect of TGF-β1 on mesothelial cells via apoptosis in early peritoneal carcinomatosis. Lv ZD; Yang ZC; Wang HB; Li JG; Kong B; Wang XG; Liu XY; Niu ZH; Wang Y; Nie G Oncol Rep; 2012 Jun; 27(6):1753-8. PubMed ID: 22447164 [TBL] [Abstract][Full Text] [Related]
14. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy. Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells. Song H; Guo B; Zhang J; Song C Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702 [TBL] [Abstract][Full Text] [Related]
16. Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination. Perry K; Wong L; Liu V; Park I; Zhang Q; Rejen V; Huang X; Smith ND; Jovanovic B; Lonning S; Teicher BA; Lee C Urology; 2008 Jul; 72(1):225-9. PubMed ID: 18295867 [TBL] [Abstract][Full Text] [Related]
17. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
18. A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells. Wu J; Liu B; Wu H; Wu Y; Zhang W; Zhao S; Zhang L; Pan X; Gao W; Wang X; Yuan Y; Zhang Y J Biomed Nanotechnol; 2016 Apr; 12(4):800-10. PubMed ID: 27301206 [TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 promotes migration and invasion of salivary adenoid cystic carcinoma. Dong L; Wang YX; Li SL; Yu GY; Gan YH; Li D; Wang CY J Dent Res; 2011 Jun; 90(6):804-9. PubMed ID: 21441221 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer. Ellermeier J; Wei J; Duewell P; Hoves S; Stieg MR; Adunka T; Noerenberg D; Anders HJ; Mayr D; Poeck H; Hartmann G; Endres S; Schnurr M Cancer Res; 2013 Mar; 73(6):1709-20. PubMed ID: 23338611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]